Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

The National Respiratory Day returns on Saturday, September 21, organized by Aipo-Its/Ets (Italian Association of Hospital ...

Mary Washington Healthcare with information to protect your family from RSV--including infants and older adults.

easing the burden on the healthcare system. Prevention of RSV in older adults is key,” he said †. If you are over 60 and have ...

The arrival of cooler weather and people gathering indoors can lead to the increased spread of COVID-19, influenza and ...

Of the eligible infants, 897 (53.4%) were infected with RSV in the first year of life and 783 (46.6%) were not. Active ...

The Upper Missouri District Health Unit (UMDHU) is urging people to get immunizations against respiratory infections.

UMDHU is encouraging you to choose to be immunized against respiratory infections. Depending on your age and health factors, these could include influenza, respiratory syncytial virus (RSV) and ...

Pfizer Canada ULC announced that ABRYSVO™ has been selected as the publicly-funded vaccine for the prevention of Respiratory ...

GSK plc (LSE/NYSE: GSK) today announced positive topline data from the phase 3 trial in adults 50 years and older evaluating the immunogenicity, reactogenicity and safety of AREXVY (Respiratory ...

The researchers found that RSV vaccines could significantly reduce the burden of disease and associated healthcare costs — but not all groups would benefit equally from a publicly funded program.

Sanofi is shipping BEYFORTUS (nirsevimab-alip) 50mg and 100mg Injection doses in the US to private healthcare providers and to the Centers for Disease Control and Prevention for its Vaccines for ...